Health care stocks were retreating Friday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) 0.2% lower.
The iShares Biotechnology ETF (IBB) fell 1.9%.
In corporate news, Eli Lilly (LLY) said Friday that data from its open-label extension study showed bowel disease drug Omvoh provided long-term clinical remission and endoscopic response to people with Crohn's disease as well as for those with prior biologic failure. Its shares rose 1.6%.
Illumina (ILMN) shares fell 8.2% after the company posted overnight lower Q4 revenue.
Ascentage Pharma (AAPG) said Friday that underwriters of its US initial public offering have partially exercised an over-allotment option to buy an additional 935,144 American depositary shares at the IPO price of $17.25 per ADS. Its shares shed 0.8%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。